Exhibit 99.01
|
Press Release
|
 |
|
www.shire.com
|
Notification of major interests in shares
November 6, 2012 - Shire plc (LSE: SHP, NASDAQ: SHPG)
|
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:
|
Shire plc
|
|
2. Reason for the notification
|
State
Yes/No
|
|
An acquisition or disposal of voting rights
|
Yes
|
|
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
|
No
|
|
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
|
Yes
|
|
An event changing the breakdown of voting rights
|
No
|
|
Other (please specify):
|
No
|
|
3. Full name of person(s) subject to the notification obligation:
|
BlackRock Inc
|
|
4. Full name of shareholder(s) (if different from 3.):
|
N/A
|
|
5. Date of the transaction (and date on which the threshold is crossed or reached if different):
|
2 November 2012
|
|
6. Date on which issuer notified:
|
6 November 2012
|
|
7. Threshold(s) that is/are crossed or reached:
|
Above 10%
|
|
8. Notified details:
|
|||||||
|
A: Voting rights attached to shares
|
|||||||
|
Class/type of shares
if possible using the ISIN CODE
|
Situation previous to
the Triggering
transaction
|
Resulting situation after the triggering
transaction
|
|||||
|
Number
of
Shares
|
Number
of
Voting
Rights
|
Number
of
shares
|
Number of voting
rights
|
% of voting
rights
|
|||
|
Direct
|
Indirect
|
Direct
|
Indirect
|
||||
|
JE00B2QKY057
|
33,336,203
|
33,336,203
|
N/A
|
N/A
|
54,260,621
|
N/A
|
9.66%
|
|
B: Qualifying Financial Instruments
|
||||
|
Resulting situation after the triggering transaction
|
||||
|
Type of financial
instrument
|
Expiration
date
|
Exercise/Conversion
Period/ Date
|
Number of voting
rights that may be
acquired if the instrument
is exercised/converted
|
% of voting
rights
|
Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX
|
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
|
||||||
|
Resulting situation after the triggering transaction
|
||||||
|
Type of financial
instrument
|
Exercise
price
|
Expiration
date
|
Exercise/
Conversion
period
|
Number of voting
rights instrument
refers to
|
% of voting rights
|
|
|
CFD
|
|
|
|
2,272,938
|
Nominal
|
Delta
|
|
0.40%
|
0.40%
|
|||||
|
Total (A+B+C)
|
|
|
Number of voting rights
|
% of voting rights
|
|
56,533,559
|
10.06
|
|
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:
|
|
BlackRock Investment Management (UK) Limited – 56,533,559 (10.06%)
|
|
Proxy Voting:
10. Name of the proxy holder:
|
N/A
|
|
11. Number of voting rights proxy holder will cease to hold:
|
N/A
|
|
12. Date on which proxy holder will cease to hold voting rights:
|
N/A
|
|
13. Additional information:
|
BlackRock Regulatory Threshold Reporting Team
|
|
14. Contact name:
|
Wayne Powell
|
|
15. Contact telephone number:
|
020 7743 2216; wayne.powell@blackrock.com
|
Contact at Shire plc: Tony Guthrie, Deputy Company Secretary, 01256 894746
For further information please contact:
|
Investor Relations
|
||
|
Eric Rojas
|
erojas@shire.com
|
+1 781 482 0999
|
|
Sarah Elton-Farr
|
seltonfarr@shire.com
|
+44 1256 894157
|
Notes to editors
Shire enables people with life-altering conditions to lead better lives.
Through our deep understanding of patients’ needs, we develop and provide healthcare in the areas of:
|
·
|
Behavioral Health and Gastro Intestinal conditions
|
|
·
|
Rare Diseases
|
|
·
|
Regenerative Medicine
|
as well as other symptomatic conditions treated by specialist physicians.
We aspire to imagine and lead the future of healthcare, creating value for patients, physicians, policymakers, payors and our shareholders.